UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 419

Sortiert nach

Non-alcoholic fatty liver disease and dyslipidemia: An update

Metabolism, clinical and experimental, 2016-08, Vol.65 (8), p.1109-1123

2016

Link zum Volltext

Verfügbarkeit prüfen

Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies

European heart journal, 2019-09, Vol.40 (34), p.2870-2879

2019

Link zum Volltext

Verfügbarkeit prüfen

Statins and diabetes mellitus progression: a fly in the ointment?

Nature reviews. Endocrinology, 2022-03, Vol.18 (3), p.137-138

2022

Link zum Volltext

Verfügbarkeit prüfen

Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways

Journal of cellular physiology, 2019-01, Vol.234 (1), p.223-230

2019

Link zum Volltext

Verfügbarkeit prüfen

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

Archives of medical science, 2020, Vol.16 (3), p.485-489

2020

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis and Acute Brain Ischemia in Ischemic Stroke

Current vascular pharmacology, 2017-03, Vol.15 (2), p.115

2017

Link zum Volltext

Verfügbarkeit prüfen

The link between insulin resistance parameters and serum uric acid is mediated by adiposity

Atherosclerosis, 2018-03, Vol.270, p.180-186

2018

Link zum Volltext

Verfügbarkeit prüfen

Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

Current vascular pharmacology, 2018-05, Vol.16 (3), p.219

2018

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update

World journal of gastroenterology : WJG, 2015-06, Vol.21 (22), p.6820-6834

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy of type 2 diabetes: An update

Metabolism, clinical and experimental, 2018-01, Vol.78, p.13-42

2018

Link zum Volltext

Verfügbarkeit prüfen

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation

Nutrition reviews, 2017-05, Vol.75 (5), p.307-326

2017

Link zum Volltext

Verfügbarkeit prüfen

Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance

Journal of diabetes and its complications, 2018-03, Vol.32 (3), p.266-270

2018

Link zum Volltext

Verfügbarkeit prüfen

The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil

Nutrients, 2019-11, Vol.11 (11), p.2833

2019

Link zum Volltext

Verfügbarkeit prüfen

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)

Pharmaceuticals (Basel, Switzerland), 2023-04, Vol.16 (4), p.577

2023

Link zum Volltext

Verfügbarkeit prüfen

NAFLD and Statins

Digestive diseases and sciences, 2020-10, Vol.65 (10), p.3052-3053

2020

Link zum Volltext

Verfügbarkeit prüfen

Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management

Current pharmaceutical design, 2017-01, Vol.23 (10), p.1522

2017

Link zum Volltext

Verfügbarkeit prüfen

The Cardiac-Kidney-Liver (CKL) syndrome: the "real entity" of type 2 diabetes mellitus

Archives of medical science, 2024-01, Vol.20 (1), p.207-215

2024

Link zum Volltext

Verfügbarkeit prüfen

Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus

Current pharmaceutical design, 2019-01, Vol.25 (18), p.2051

2019

Link zum Volltext

Verfügbarkeit prüfen

A Greater Flavonoid Intake Is Associated with Lower Total and Cause-Specific Mortality: A Meta-Analysis of Cohort Studies

Nutrients, 2020-08, Vol.12 (8), p.2350

2020

Link zum Volltext

Verfügbarkeit prüfen

The Role of n-3 Fatty Acids in Cardiovascular Disease: Back to the Future

Angiology, 2020-01, Vol.71 (1), p.10-16

2020

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?

Current vascular pharmacology, 2019-01, Vol.17 (4), p.421

2019

Link zum Volltext

Verfügbarkeit prüfen

Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022)

Cardiovascular diabetology, 2022-11, Vol.21 (1), p.263-263, Article 263

2022

Link zum Volltext

Verfügbarkeit prüfen

Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term

Circulation research, 2022-04, Vol.130 (9), p.1276-1285

2022

Link zum Volltext

Verfügbarkeit prüfen

Longer sleep duration may negatively affect renal function

International urology and nephrology, 2021-02, Vol.53 (2), p.325-332

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 419

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(351)
Mit Volltextzugriff
(290)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(352)
Life Sciences & Biomedicine
(350)
Humans
(271)
Cardiovascular System & Cardiology
(146)
Pharmacology & Pharmacy
(93)
Peripheral Vascular Disease
(91)
Male
(80)
Female
(78)
Risk Factors
(76)
Cardiac & Cardiovascular Systems
(64)
Cardiovascular Disease
(56)
Endocrinology & Metabolism
(54)
Statins
(50)
Diabetes
(46)
General & Internal Medicine
(46)
Medicine, General & Internal
(46)
Animals
(41)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(39)
Metabolic Syndrome
(39)
Middle Aged
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Non-alcoholic fatty liver disease and dyslipidemia: An update

Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies

Statins and diabetes mellitus progression: a fly in the ointment?

Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

Apoptosis and Acute Brain Ischemia in Ischemic Stroke

The link between insulin resistance parameters and serum uric acid is mediated by adiposity

Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update

Pharmacotherapy of type 2 diabetes: An update

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation

Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)

NAFLD and Statins

Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management

The Cardiac-Kidney-Liver (CKL) syndrome: the "real entity" of type 2 diabetes mellitus

Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus

A Greater Flavonoid Intake Is Associated with Lower Total and Cause-Specific Mortality: A Meta-Analysis of Cohort Studies

The Role of n-3 Fatty Acids in Cardiovascular Disease: Back to the Future

Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?

Personalized management of dyslipidemias in patients with diabetes-it is time for a new approach (2022)

Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term

Longer sleep duration may negatively affect renal function

Suchergebnisse filtern